Intended for healthcare professionals

CCBYNC Open access
Research

Disease activity guided dose reduction and withdrawal of adalimumab or etanercept compared with usual care in rheumatoid arthritis: open label, randomised controlled, non-inferiority trial

BMJ 2015; 350 doi: https://doi.org/10.1136/bmj.h1389 (Published 09 April 2015) Cite this as: BMJ 2015;350:h1389